Charles Herbaux, MD, MSc¹, Imelda Raczkiewicz^2*, Kamel Laribi, MD^3*, Loic Ysebaert, MD, PhD^4*, Agnes Daudignon^5*, Sabine Tricot^6*, Aurelie Caillault-Venet^7*, Alain Jacques Delmer, MD, PhD⁸, Pascale Cornillet-Lefebvre^9*, Cymbalista Florence^10*, Virginie Eclache^11*, Pierre Morel, MD^12*, Gauthier Decool^7*, Morgane Nudel^13*, Romain Guieze, MD^14*, Liam Hackett, BS^15*, Stephen Jun Fei Chong^16*, Mary C Collins, BS^16*, Florence Nguyen-Khac, MD, PhD^17*, Fatiha Merabet, MD^18*, Jasmine Chauzeix^19*, Stéphanie Struski, MD^20*, Jennifer R. Brown, MD, PhD^21*, Matthew S. Davids, MD²¹ and Stéphanie Poulain, MD, PhD^22*

¹Department of Medical Oncology, Dana-Farber Cancer Institute, BROOKLINE, MA
²CHU Lille, Lille, FRA
³Centre Hospitalier Du Mans, Le Mans, France
⁴Department of Hematology, Institut Universitaire Cancerologie Toulouse-Oncopole, Toulouse, France
⁵CHU de Lille, Cytogenetic Unit, Lille, France
⁶Hematology Unit, Arras, France
⁷Centre de Biologie Pathologie, Service d’Hématologie Cellulaire, Lille, France
⁸Hematology Department, Robert Debré University Hospital, Reims, Cedex, France
⁹Hematology Biology, Reims University Hospital, Reims, France
¹⁰Service d’hématologie biologique, Bobigny Cedex, France
¹¹APHP, Bobigny, FRA
¹²Department of Hematology, Chu Amiens, Salouel, France
¹³Hematology Unit, Lille, France
¹⁴CHU Estaing, Unit of adult cell therapy and clinical hematology, University Hospital of Clermont-Ferrand, Brookline, MA
¹⁵Dana-Farber Cancer Institute, Boston, MA
¹⁶Dana Farber Cancer Institute, Boston
¹⁷Hematologie Biologique, APHP Pitié Salpêtrière, Paris, France
¹⁸Service Hématologie et Oncologie, Hôpital André Mignot, Le Chesnay, France
¹⁹Service d’Hématologie Biologique, Limoges, France
²⁰Institut Universitaire du Cancer de Toulouse, Toulouse, France
²¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²²Service d'Hématologie Cellulaire, Centre de Biologie et Pathologie, CHRU de Lille, France/ INSERM UMR-S 1172, IRCL, Lille, FRA

Hanyin Wang, MD^1*, Shulan Tian, MS, PhD^2*, Qing Zhao^3*, Wendy Blumenschein^3*, Jennifer H. Yearley, PhD^3*, Charla R. Secreto^4*, Sutapa Sinha, PhD⁴, Timothy G. Call, MD⁴, Yucai Wang, MD, PhD⁴, Sameer A. Parikh, MD⁴, Saad S. Kenderian, MD⁴, Rong He, MD⁵, Jose F. Leis, MD, PhD⁶, Min Shi, MD, PhD⁵, Neil E. Kay, MD⁴, Susan L. Slager, PhD^2*, Esteban Braggio, PhD⁷, Huihuang Yan, PhD^2* and Wei Ding, MD, PhD⁴

¹Department of Hospital Medicine, Mayo Clinic Health System, Mankato, MN
²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
³Merck & Co., Inc., Kenilworth, NJ
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁶Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ

Riccardo Moia, MD^1*, Chiara Favini, PhD^1*, Valentina Ferri, PhD^1*, Riccardo Bomben, PhD^2*, Sruthi Sagiraju, MSc^1*, Tamara Bittolo, PhD^2*, Lydia Scarfo^3*, Silvia Bonfiglio^3*, Rossana Maffei⁴, Stefano Baldoni^5*, Sara Raponi, PhD^6*, Valeria Spina, PhD^7*, Alessio Bruscaggin, PhD⁷, Lodovico Terzi di Bergamo^8*, Lorenzo De Paoli^1*, Gloria Margiotta Casaluci^1*, Clara Deambrogi, PhD^1*, Silvia Rasi^1*, Adalgisa Condoluci, MD^8*, Ahad Ahmed Kodipad, Msc^1*, Ramesh Adhinaveni, Msc^1*, Katia Mokabari^1*, Abdurraouf Mokhtar Mahmoud, MSc^1*, Andrea Patriarca, MD^1*, Jacopo Olivieri^9*, Giovanni D'Arena, MD¹⁰, Francesco Zaja^11*, Annalisa Chiarenza, MD, PhD^12*, Giovanni Del Poeta, MD¹³, Antonella Zucchetto, PhD^2*, Francesca Maria Rossi, PhD^2*, Ilaria Del Giudice, MD, PhD^6*, Paolo Sportoletti, MD^5*, Roberto Marasca, MD¹⁴, Paolo Ghia, MD, PhD³, Robin Foà, MD⁶, Gianluca Gaidano¹, Davide Rossi, MD, PhD⁸ and Valter Gattei, MD¹⁵

¹Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
²Clinical and Experimental Onco-Hematology Unit, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
³Division of Experimental Oncology, Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy
⁴Hematology Unit, A.O.U of Modena-Policlinico Department of Oncology and Hematology, Italy, Modena, Italy
⁵Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
⁶Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
⁷Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
⁸Institute of Oncology Research, Bellinzona, Switzerland
⁹Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" Dipartimento Interaziendale di Salute Mentale, AO Universitaria S. Maria Misericordia, Udine, Italy., Udine, Italy
¹⁰IRCCS Centro Di Riferimento Oncologico Della Basilicata, Rionero In Vulture, ITA
¹¹Institute of Hematology, University and Hospital of Trieste, Trieste, Italy
¹²AOU Policlinico, University of Catania, Division of Hematology, Catania, Italy
¹³Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
¹⁴Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
¹⁵Clinical and Experimental Onco-Hematology Unit, Centro Di Riferimento Oncologico, Aviano, Italy

Andrea Visentin, MD PhD^1*, Gian Matteo Rigolin^2*, Francesca Romana Mauro, MD, PhD^3*, Annalisa Martines, PhD^4*, Federica Frezzato, PhD^5*, Silvia Imbergamo, MD^6*, Stefano Pravato, MD^6*, Leila Romano Gargarella, MD^6*, Maria Antonella Bardi^7*, Mauro Nanni, PhD^3*, Francesco Piazza⁸, Monica Facco, MS^9*, Robin Foà, MD³, Gianpietro Semenzato, MD^10*, Laura Bonaldi, MD^11*, Antonio Cuneo, MD^12* and Livio Trentin, MD¹³

¹Hematology and Clinical Immunology Unit, Department of Medicine, Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy
²Hematology, St. Anna University Hospital, Cona, Ferrara, Italy
³Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
⁴Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padova, Italy
⁵Hematology and Clinical Immunology unit, Department of Medicine, University of Padua, Padova, Italy
⁶Hematology and Clinical Immunology unit, Department of Medicine, University of Padua, Padua, Italy
⁷Haematology Section, Ferrara, ITA
⁸Hematology and Clinical Immunology Unit, Department of Medicine, University of Padova, Padua, Italy
⁹Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Pa, ITA
¹⁰Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy
¹¹Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS, Padua, Italy
¹²Hematology section, Department of Medical Sciences, University of Ferrara - Azienda Ospedaliera-Universitaria di Ferrara, University of Ferrara, Ferrara, Italy
¹³Hematology and Clinical Immunology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy

Selcen Oeztuerk^1*, Murat Iskar, PhD^1*, Murat Sunbul, PhD^2*, Philipp M Rößner, MD^1*, Marc Zapatka, PhD^1* and Martina Seiffert^1*

¹Molecular Genetics, German Cancer Research Center, Heidelberg, Germany
²Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg, Germany

Zhenghao Chen^1,2*, Gaspard Cretenet^1*, Valeria Carnazzo^1,3*, Gerritje J. W. van der Windt^1*, Arnon P. Kater, MD, PhD^2,4 and Eric Eldering, PhD^1,2*

¹Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
²Amsterdam Institute of Infection and Immunity, Cancer Center Amsterdam, and Lymphoma and Myeloma Center (LYMMCARE), Amsterdam, Netherlands
³Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy
⁴Department of Hematology, Academic Medical Center, Amsterdam, NH, Netherlands

Geffen Kleinstern, PhD¹, J. Brice Weinberg, MD^2,3,4,5, Sameer A. Parikh, MD⁶, Esteban Braggio, PhD⁷, Dennis P. Robinson^8*, Aaron D. Norman, MPH^8*, Kari G Rabe^8*, Celine M. Vachon, PhD⁹, Connie E. Lesnick^8*, Timothy G. Call, MD⁶, Danielle M. Brander, MD^10,11, Janet E. Olson, PhD^8*, James R. Cerhan, MD, PhD⁸, Neil E. Kay, MD⁶, Curtis A. Hanson, MD^6*, Richard R. Furman, MD^12,13, Tait Shanafelt, MD¹⁴ and Susan L. Slager, PhD¹

¹Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
²Durham VA Medical Center, Durham, NC
³Division of Hematology, VA & Duke Medical Centers, Durham, NC
⁴Duke University Medical Center, Durham, NC
⁵Department of Hematology, Duke University, Durham, NC
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Mayo Clinic, Phoenix, AZ
⁸Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁹Division of Epidemiology, Mayo Clinic, Rochester, MN
¹⁰Department of Medicine, Duke University Medical Center, Durham, NC
¹¹Duke Cancer Institute, Duke University, Durham, NC
¹²Morton Coleman, M.D. Distinguished Professor of Medicine Weill Cornell Medical College, New York, NY
¹³Weill Cornell Medical College, New York, NY
¹⁴Stanford University Medical Center, Stanford, CA

Zhenghao Chen^1,2*, Gaspard Cretenet^1*, Beatriz Valle-Argos^3*, Francesco Forconi, MD, PhD, FRCPath^4*, Arnon P. Kater, MD, PhD^2,5, Graham Packham, PhD^3* and Eric Eldering, PhD^1,2*

¹Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
²Amsterdam Institute of Infection and Immunity, Cancer Center Amsterdam, and Lymphoma and Myeloma Center (LYMMCARE), Amsterdam, Netherlands
³Cancer Research UK Centre, Cancer Sciences, University of Southampton, Southampton, United Kingdom
⁴Department of Haematology, Southampton University Hospital Trust, Southampton, United Kingdom
⁵Department of Hematology, Academic Medical Center, Amsterdam, NH, Netherlands

Monica Else, MA, MSc^1*, Stuart J Blakemore, PhD^2,3*, Jonathan C Strefford, PhD² and Daniel Catovsky, MD, FRCP⁴

¹Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
²Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
³Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany
⁴The Institute of Cancer Research, London, United Kingdom

Yang Liang, MD¹, Han-ying Huang^2*, Yun Wang, MD, PhD^2*, Weida Wang, MD, PhD^2* and Huan-xin Lin^2*

¹Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
²State Key Laboratory of Oncology in South China; Collaborative Innovation Center of Cancer Medicine; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China